WallStreetZenWallStreetZen

NASDAQ: REPL
Replimune Group Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

REPL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$210.0M
Current Profit Margin
0%

REPL Return on Equity

Current Company
-42.9%
Current Industry
-63.5%
Current Market
188%
REPL's Return on Equity (-42.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when REPL announces earnings.

REPL Return on Assets

Current Company
-35.8%
Current Industry
2.9%
REPL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

REPL Return on Capital Employed

Current Company
-41.05%
Current Industry
19.5%
REPL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

REPL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
REPL$0.00-$200.44M-$209.96MN/AN/A
LXRX$1.20M-$163.46M-$177.12M-54.71%N/A
TVTX$145.24M-$61.31M-$111.40M-2.43%N/A
ITOS$12.60M-$108.13M-$112.64M-80.89%N/A
BMEA$0.00-$113.05M-$117.26MN/AN/A
View Top Biotech Stocks

REPL earnings dates

Next earnings date
May 16, 2024

Replimune Group Earnings & Revenue FAQ

What were REPL's earnings last quarter?

On Invalid Date, Replimune Group (NASDAQ: REPL) reported Q4 2023 earnings per share (EPS) of -$0.77, up 11.59% year over year. Total Replimune Group earnings for the quarter were -$51.12 million. In the same quarter last year, Replimune Group's earnings per share (EPS) was -$0.69.

If you're new to stock investing, here's how to buy Replimune Group stock.

What was REPL's earnings growth in the past year?

As of Q2 2024, Replimune Group's earnings has grown year over year. Replimune Group's earnings in the past year totalled -$209.96 million.

What is REPL's earnings date?

Replimune Group's earnings date is Invalid Date. Add REPL to your watchlist to be reminded of REPL's next earnings announcement.

What was REPL's revenue last quarter?

On Invalid Date, Replimune Group (NASDAQ: REPL) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Replimune Group's revenue was $0.00.

What was REPL's revenue growth in the past year?

As of Q2 2024, Replimune Group's revenue has grown null year over year. Replimune Group's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.